Amicus Therapeutics Company Profile

Aggregated data from the web about Amicus Therapeutics

Company Name	Amicus Therapeutics
Website	https://www.amicusrx.com
Snippet	Amicus Therapeutics informs you that our website uses its own and third party cookies to improve our services and collect statistical information about your browsing. By clicking accept, we consider that you accept its use. For more information, or to know how to change the configuration, ...
Type	Public
Founded	2002
Revenue	$91,245,000 (2018), $36,930,000 (2017)
Website	www.amicusrx.com
Industry	Biotechnology
Traded as	NASDAQ: FOLDRussell 2000 Component
Key people	John Crowley(Chairman and Chief Executive Officer)Bradley Campbell(President and Chief Operating Officer)Daphne Quimi(Chief Financial Officer)David Clark(Chief People Officer)
Net income	($349,089,000) (2018), ($449,121,000) (2017)
Headquarters	Cranbury, New Jersey, United States
Total assets	$789,951,000 (2018), $627,024,000 (2017)
Total equity	$342,912,000 (2018), $352,850,000 (2017)
Operating income	($328,777,000) (2018), ($441,985,000) (2017)
Number of employees	508 (31 Dec 2018)[1]:28

Amicus Therapeutics is part of the United States company list

Amicus Therapeutics is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.